Mwangi DW, Mukuria JC, Noguchi A.Serum Hanganutziu and Deicher (HD) antibody and total sialic acid levels in hepatoma patients.Afr J Health Sci. 1998;5(1-2):108-12.

Citation:
C PROFMUKURIAJOSEPH. "Mwangi DW, Mukuria JC, Noguchi A.Serum Hanganutziu and Deicher (HD) antibody and total sialic acid levels in hepatoma patients.Afr J Health Sci. 1998;5(1-2):108-12.". In: Afr J Health Sci. 1998;5(1-2):108-12. Plant Molecular Biology Reporter Vol. 27, pp. 79-85.; 1998.

Abstract:

A preliminary short follow-up study of Hanganutziu and Deicher (HD) antibody titre and sialic acid levels in sera from 7 patients with hepatoma was carried out. Weekly HD antibody titres were abnormal in 6 patients with titres of 4 of the 6 falling to normal in some weeks. Sialic acids levels, however were abnormal (3.830-6.82mmol/ l) compared to those of 33 normal sera (1.08-2.73 mmol/1) throughout the 8 week screening period. There was a poor correlation between the antibody tires and the sialic acid levels (r<0.50) suggesting that at some stage of malignancy, the tumour was expressing N-glycolylneuraminic acid (Neu5Gc), the epitope of HD antigens as well as shedding into circulation, excess N-acetylneuraminic acid (Neu5Gc). Neu5Gc is a tumor-associated antigen. Measurement of antibodies to this epitope have shown that the antibodies have a potential of offering an alternative method of determining tumor growth and/or metastases. A major follow-up study incorporating information on cancer type, disease stage, therapy and the immnunological status of the patient is called for.

Notes:

n/a

Website

UoN Websites Search